Advertisement
Advertisement
TMCI
Treace Medical Concepts, Inc. Common Stock
4.76
USDSponsored
+0.38
+8.68%
Aug 07, 15:59 UTC -4
Closed
After-Market
4.75
-0.01
-0.32%
TMCI Earnings Reports
Positive Surprise Ratio
TMCI beat 17 of 22 last estimates.
77%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$48.88M
/-$0.25
Implied change from Q2 26 (Revenue/ EPS)
+7.71%
/+4.17%
Implied change from Q3 25 (Revenue/ EPS)
-2.66%
/-3.85%
Treace Medical Concepts, Inc. Common Stock earnings per share and revenue
On Aug 07, 2026, TMCI reported earnings of -0.24 USD per share (EPS) for Q2 26, beating the estimate of -0.30 USD, resulting in a 21.05% surprise. Revenue reached 45.38 million, compared to an expected 44.90 million, with a 1.07% difference. The market reacted with a +8.68% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of -0.25 USD, with revenue projected to reach 48.88 million USD, implying an increase of 4.17% EPS, and increase of 7.71% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.36
Surprise
+1.96%
FAQ
What were Treace Medical Concepts, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Treace Medical Concepts, Inc. Common Stock reported EPS of -$0.24, beating estimates by 21.05%, and revenue of $45.38M, 1.07% above expectations.
How did the market react to Treace Medical Concepts, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 8.68%, changed from $4.38 before the earnings release to $4.76 the day after.
When is Treace Medical Concepts, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Treace Medical Concepts, Inc. Common Stock's next earnings report?
Based on 8
analysts, Treace Medical Concepts, Inc. Common Stock is expected to report EPS of -$0.25 and revenue of $48.88M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement